Roundtable on Translational Cancer Research Trends
June 18, 2012 | Bio-IT World | One of the highlights of the 10th anniversary Bio-IT World Conference last April was a plenary roundtable on translational cancer research, featuring four outstanding cancer researchers: computational biologist John Quackenbush (Dana-Farber Cancer Institute); drug discoverer Julian Adams (Infinity Pharmaceuticals); clinical researcher Jose Baselga (Mass General Hospital, Boston); and geneticist Sir John Burn, (Institute of Genetic Medicine, Newcastle University, UK/QuantuMDx). The panel was moderated by Bio-IT World editor Kevin Davies and can be viewed in full online.
